What are Key Factors Propelling Growth of Global Medical Robotic Systems Market? Key Players are Hocoma AG, Capsa Healthcare, Medrobotics Corporation, Titan Medical Inc., ARxIUM, Omnicell, Globus Medical, Stryker, Johnson & Johnson, Hansen Medical

The increasing geriatric population across the world is one of the key factors responsible for the surging usage of medical robotic systems. Moreover, the rising healthcare costs and dwindling number of healthcare providers and caregivers are significantly boosting the need for alternative caregiving methods. According to the American Association of Retired Persons (AARP), seven people in the age group 45-64 can provide care for every person aged 80 years and above, and this number will decrease massively by 2030, with only 4 people available for providing care for people aged 80 years and above.

Global Medical Robotic Systems Market Key Companies are:
1- Hocoma AG
2- Capsa Healthcare
3- Medrobotics Corporation,
4- Titan Medical Inc.
5- ARxIUM
6- Omnicell
7- Globus Medical
8- Stryker
9- Johnson & Johnson
10- Hansen Medical

Download sample copy of this report@ https://www.psmarketresearch.com/market-analysis/medical-robotic-systems-market/report-sample

The other major factors pushing the adoption of robotics in the medical sector are the burgeoning use of automated pharmacy systems across the world and increasing demand for medical procedures. Since the last few years, there has been a massive surge in the adoption of automated systems in the healthcare and pharmaceutical sectors, in order to streamline the work processes and optimize the services. Propelled by these factors, the global medical robotic systems market revenue is expected to increase from $7,626.1 million in 2019 to $55,528.1 million by 2030, exhibiting a CAGR of 20.1% during the forecast period (2020-2030).

The biggest trend presently being witnessed in the medical robotic systems market is the soaring number of technological developments. For instance, the California Institute of Technology (Caltech) is working on a microbot target therapy that utilizes near-microscopic mechanical particles for drug localization and administration to a certain part inside the human body, while being managed and controlled from the outside. Microbots, which consist of a coating of platelets and red blood cells and nanowires, are increasingly being deployed for destroying tumors via radiation and reducing the side-effects of medication.

Browse full report at@ https://www.psmarketresearch.com/market-analysis/medical-robotic-systems-market

Market Segmentation by Type
o Surgical
o Automated Dispenser
o Rehabilitation
o Radiosurgery
o Others
Market Segmentation by Application
o Treatment
o Pharmacy Automation
o Others
Market Segmentation by Indication
o Urology
o Gynecology
o Cardiothoracic Surgery
o Orthopedics
o Neurosurgery
o Others
Market Segmentation by End User
o Hospitals and Ambulatory and Surgery Centers (ASCs)
o Pharmacies
o Rehabilitation Centers
o Others

This study covers

o Historical and the present size of the medical robotic systems market
o Major factors driving the market and their impact during the short, medium, and long terms
o Market restraints and their impact during the short, medium, and long terms
o Recent trends and evolving opportunities for the market participants
o Historical and the present size of the market segments and understand their comparative future potential

Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: http://psintelligence.blogspot.com/

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.